Brain Tumor Imaging Study Using Advanced CT Scans
Part of Brain & nervous system, Cancer clinical trials.
This study examines how a specialized CT scanner (Spectral CT) captures detailed images of brain tumors. Researchers will review your imaging scans to understand how well this technology helps doctors see and understand brain tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a brain tumor confirmed by MRI or CT scan
- Your CT scan was done using the Spectral CT 7500 machine
- You are at least 18 years old
- Your medical records and imaging scans are complete and available for review
- You are willing to sign a consent form allowing researchers to use your medical information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at brain tumors (both new and returning) to help doctors understand them better and see how well treatment is working.
This trial tests a new imaging agent (99mTc-CNDG) to see if it can help doctors see brain tumors better on a SPECT/CT scan. It might provide more information than standard scans and could help guide treatment decisions.
This study looks at whether a special type of MRI scan (magnetic resonance spectroscopy) can give more information about your glioblastoma tumor. It may help doctors better understand your tumor and guide future treatment decisions.
This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.
This study looks back at your CT scans to see if a new imaging technique can better show colon cancer details. Your participation simply allows researchers to review your existing scans and health records — no extra visits or treatments are needed.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
Hear when a new Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.